Acupuncture for chronic pelvic pain with sequelae of pelvic inflammatory disease: a multicenter, randomized, parallel controlled trial

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: Not specified

Inclusion Criteria

1. Those who meet the diagnostic criteria of traditional Chinese and Western medicine for the sequelae of pelvic inflammatory disease (chronic pelvic pain);
2. Patients aged 20-50 with sexual life history;
3. Regular menstrual cycle (24-37 days); normal menstrual cycle (3-7 days);
4. VAS score of lower abdominal pain >=3; VAS score of lumbosacral pain >=3;
5. Those who voluntarily participated in the study and signed the informed consent.

Exclusion Criteria

1. Those who do not meet the inclusion criteria;
2. Pregnant or half a year to prepare for pregnancy or lactation, menopausal women;
3. It is confirmed by examination that the related symptoms are caused by gynecological tumors (except those with the largest diameter of uterine fibroids < 2cm), endometriosis, adenomyosis, acute cervicitis, specific vaginitis, pelvic venous congestion syndrome, tuberculous pelvic inflammation, perineal nerve block, digestive system diseases, urinary system diseases and other diseases;
4. Acute attack of pelvic inflammation or pelvic abscess;
5. The complications include cardiovascular disease, hepatorenal disease, hematological disease, neuropsychiatric disease or other serious diseases that may hinder the entry or affect their survival, such as tumor, asthma, etc;
6. Those who have scars on the needle application site, are sensitive to acupuncture or have fainting needles, or those who are considered by researchers to have systemic diseases due to improper measures taken at the needle application site;
7. Patients in other clinical trials;
8. Suspect or have a history of alcohol or drug abuse, or according to the judgment of the researcher, have other diseases or conditions that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in the working environment, unstable living environment and other situations that are likely to cause lost visits;
9. Allergic constitution or allergic to NSAIDs;
10. Those who have received relevant treatment or drugs with similar functions within two weeks.

Study & Design

Study Type: Interventional study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Abdominal pain vas scale score, lumbosacral pain vas scale score, pain duration, TCM Syndrome Scale score, WHOQOL-BREF scale, local signs scale score;

Secondary Outcome Measures